Plasma haemoxygenase-1 in coronary artery disease A comparison with angiogenin, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and vascular endothelial growth factor

NK Idriss, Gregory Lip, B Balakrishnan, Rumi Jaumdally, Christopher Boos, Andrew Blann

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

It was the aim of this study to determine plasma haemoxygenase 1 (HO 1) across the spectrum of health, angina but normal coronary arteries (NCA) stable coronary artery disease (CAD) and acute coronary syndromes (ACS) and relationships with angiogenin matrix metallo proteinase 9 (MMP 9), tissue inhibitor of metalloproteinase 1, and vascular endothelial growth factor Plasma markers were measured (ELISA) in peripheral venous citrated plasma from 50 healthy subjects 30 with NCA, 70 with stable CAD and 24 with an ACS and from patient s aortic root coronary ostium coronary sinus and femoral artery Human umbilical vein endothelial cells (HUVECs) were cultured with or without tumour necrosis factor (TNF) and platelets were probed HO 1 was raised in stable CAD (p
Original languageEnglish
Pages (from-to)1029-1037
Number of pages9
JournalThrombosis and Haemostasis
Volume104
Issue number5
DOIs
Publication statusPublished - 1 Nov 2010

Keywords

  • coronary artery disease
  • vascular endothelial growth factor
  • tissue inhibitor of metalloproteinase
  • Haemoxygenase 1 angiogenin matrix metalloproteinase 9

Fingerprint

Dive into the research topics of 'Plasma haemoxygenase-1 in coronary artery disease A comparison with angiogenin, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and vascular endothelial growth factor'. Together they form a unique fingerprint.

Cite this